Max Robotics — Global Service Robot Directory + US Certification

About

Neil Mundi is a head and neck surgical oncologist whose research focuses on advancing treatment for oropharyngeal cancer and carcinoma of unknown primary (CUP) in the head and neck. His major contributions center on evaluating outcomes of modern therapeutic approaches, particularly intensity-modulated radiation therapy (IMRT) and transoral robotic surgery (TORS). In his highly cited 2020 study (13 citations), Mundi demonstrated that early T-stage oropharyngeal cancer patients treated with IMRT at a tertiary care institution achieved excellent modern treatment outcomes, providing critical benchmarks for comparing surgical and radiotherapeutic modalities. His 2022 work (7 citations) examined how transoral robotic mucosectomies (TORM) improve primary tumor identification rates in neck CUP patients, while also analyzing the consequential treatment delays—a pragmatic assessment of this increasingly popular technique’s real-world impact. By quantifying both the benefits and costs of TORS-based approaches, Mundi’s research helps guide clinical decision-making for two challenging clinical scenarios. His work is essential reading for surgeons and radiation oncologists seeking evidence-based comparisons of treatment paradigms in the evolving landscape of head and neck cancer care.